Oruka Therapeutics Inc (ORKA)

Currency in USD
32.580
+1.160(+3.69%)
Real-time Data·
ORKA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
31.38032.915
52 wk Range
5.48536.510
Key Statistics
Prev. Close
31.42
Open
32.03
Day's Range
31.38-32.915
52 wk Range
5.485-36.51
Volume
127.49K
Average Volume (3m)
535.8K
1-Year Change
149.0826%
Book Value / Share
10
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORKA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.667
Upside
+70.86%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Oruka Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Oruka Therapeutics Inc Company Profile

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Compare ORKA to Peers and Sector

Metrics to compare
ORKA
Peers
Sector
Relationship
P/E Ratio
−18.7x−2.0x−0.5x
PEG Ratio
-0.160.00
Price/Book
3.2x2.5x2.6x
Price / LTM Sales
-104.1x3.3x
Upside (Analyst Target)
68.7%93.8%48.1%
Fair Value Upside
Unlock13.2%7.7%Unlock

Analyst Ratings

13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 55.667
(+70.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Clear Street
Buy71.00+117.72%46.00MaintainJan 13, 2026
UBS
Buy50.00+53.33%-New CoverageJan 07, 2026
Wolfe Research
Buy58.00+77.86%26.00MaintainJan 06, 2026
Piper Sandler
Buy75.00+129.99%-New CoverageDec 18, 2025
BTIG
Buy63.00+93.19%56.00MaintainNov 13, 2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.69 / -0.70
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ORKA Income Statement

People Also Watch

65.89
ARWR
+1.93%
152.41
INSM
+0.91%
29.71
TVTX
+0.81%
85.74
IONS
+2.71%
166.16
JAZZ
+1.84%

FAQ

What Is the Oruka Therapeutics (ORKA) Stock Price Today?

The Oruka Therapeutics stock price today is 32.580

What Stock Exchange Does Oruka Therapeutics Trade On?

Oruka Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Oruka Therapeutics?

The stock symbol for Oruka Therapeutics is "ORKA."

What Is the Oruka Therapeutics Market Cap?

As of today, Oruka Therapeutics market cap is 1.57B.

What Is Oruka Therapeutics's Earnings Per Share (TTM)?

The Oruka Therapeutics EPS (TTM) is -1.95.

From a Technical Analysis Perspective, Is ORKA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Oruka Therapeutics Stock Split?

Oruka Therapeutics has split 6 times.

How Many Employees Does Oruka Therapeutics Have?

Oruka Therapeutics has 28 employees.

What is the current trading status of Oruka Therapeutics (ORKA)?

As of Feb 06, 2026, Oruka Therapeutics (ORKA) is trading at a price of 32.580, with a previous close of 31.420. The stock has fluctuated within a day range of 31.380 to 32.915, while its 52-week range spans from 5.485 to 36.510.

What Is Oruka Therapeutics (ORKA) Price Target According to Analysts?

The average 12-month price target for Oruka Therapeutics is USD55.667, with a high estimate of USD75 and a low estimate of USD40. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +70.86% Upside potential.

What Is the ORKA After Hours Price?

ORKA's last after hours stock price is 31.110, the stock has decreased by -0.310, or -0.990%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.